- Home
- SWRD vs RLMD Comparison
SWRD vs RLMD Comparison
Compare SWRD & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWRD | RLMD |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.0M | 461.9M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | SWRD | RLMD |
|---|---|---|
| Price | $2.15 | $4.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.40 |
| AVG Volume (30 Days) | 325.9K | ★ 1.1M |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $1.79 | $1.53 |
| 52 Week High | $2.15 | $8.00 |
Technical Indicators
Market Signals| Indicator | SWRD | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.52 |
| Support Level | N/A | $3.99 |
| Resistance Level | N/A | $4.51 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 30.00 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.